Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Stoessl

Showing results (31-40 of 102) with videos related to

Pageof 11
Sort By:
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 1, 1986
Dementia in movement disordersH Teräväinen, M Hietanen, J Stoessl, et al.
Stroke|July 1, 1985
Intracerebral haemorrhage and angiographic beading following ingestion of catecholaminergicsA J Stoessl, G B Young, T E Feasby
Psychopharmacology|January 1, 1989
Chronic neuroleptic-induced mouth movements in the rat: suppression by CCK and selective dopamine D1 and D2 receptor antagonistsA J Stoessl, C T Dourish, S D Iversen
Psychopharmacology|January 1, 1988
The NK-3 tachykinin agonist senktide elicits yawning and chewing mouth movements following subcutaneous administration in the rat. Evidence for cholinergic mediationA J Stoessl, C T Dourish, S D Iversen
Brain Research|May 28, 1990
Pharmacological characterization of the behavioural syndrome induced by the NK-3 tachykinin agonist senktide in rodents: evidence for mediation by endogenous 5-HTA J Stoessl, C T Dourish, S D Iversen
Neuropharmacology|January 1, 1997
The neurotensin antagonist SR 48692 fails to modify the behavioural responses to a dopamine D1 receptor agonist in the ratA J Stoessl, K A James, B J Napier
Brain Research|November 29, 1991
Behavioural effects of selective tachykinin agonists in midbrain dopamine regionsA J Stoessl, E Szczutkowski, B Glenn, et al.
British Journal of Pharmacology|June 1, 1988
The NK-3 tachykinin receptor agonist senktide elicits 5-HT-mediated behaviour following central or peripheral administration in mice and ratsA J Stoessl, C T Dourish, S D Iversen
Synapse (New York, N.Y.)|July 1, 1997
Effects of intrastriatal infusion of D2 receptor antisense oligonucleotide on apomorphine-induced behaviors in the ratN Rajakumar, L Laurier, H B Niznik, et al.
Journal of Neural Transmission. Supplementum|October 5, 2006
Placebo effect and dopamine releaseR de la Fuente-Fernández, S Lidstone, A J Stoessl
Pageof 11

Showing results (31-40 of 102) with videos related to

Sort By:
Pageof 11
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 1, 1986
Dementia in movement disordersH Teräväinen, M Hietanen, J Stoessl, et al.
Stroke|July 1, 1985
Intracerebral haemorrhage and angiographic beading following ingestion of catecholaminergicsA J Stoessl, G B Young, T E Feasby
Psychopharmacology|January 1, 1989
Chronic neuroleptic-induced mouth movements in the rat: suppression by CCK and selective dopamine D1 and D2 receptor antagonistsA J Stoessl, C T Dourish, S D Iversen
Psychopharmacology|January 1, 1988
The NK-3 tachykinin agonist senktide elicits yawning and chewing mouth movements following subcutaneous administration in the rat. Evidence for cholinergic mediationA J Stoessl, C T Dourish, S D Iversen
Brain Research|May 28, 1990
Pharmacological characterization of the behavioural syndrome induced by the NK-3 tachykinin agonist senktide in rodents: evidence for mediation by endogenous 5-HTA J Stoessl, C T Dourish, S D Iversen
Neuropharmacology|January 1, 1997
The neurotensin antagonist SR 48692 fails to modify the behavioural responses to a dopamine D1 receptor agonist in the ratA J Stoessl, K A James, B J Napier
Brain Research|November 29, 1991
Behavioural effects of selective tachykinin agonists in midbrain dopamine regionsA J Stoessl, E Szczutkowski, B Glenn, et al.
British Journal of Pharmacology|June 1, 1988
The NK-3 tachykinin receptor agonist senktide elicits 5-HT-mediated behaviour following central or peripheral administration in mice and ratsA J Stoessl, C T Dourish, S D Iversen
Synapse (New York, N.Y.)|July 1, 1997
Effects of intrastriatal infusion of D2 receptor antisense oligonucleotide on apomorphine-induced behaviors in the ratN Rajakumar, L Laurier, H B Niznik, et al.
Journal of Neural Transmission. Supplementum|October 5, 2006
Placebo effect and dopamine releaseR de la Fuente-Fernández, S Lidstone, A J Stoessl
Pageof 11